Abstract
AbstractHuman hepatitis A virus was attenuated in virulence for marmosets by passage in FRhK6 and human diploid lung fibroblast cell cultures. A number of variants were produced that showed different levels of virulence/attenuation for marmosets. Marmosets that had attenuated virus-like responses following injection of variant virus were challenged with virulent virus; all were solidly immune to infection. Antibody stimulated by the vaccine equated with protection. These findings show that human hepatitis A virus can be attenuated and show the feasibility for eventual development of a live, attenuated hepatitis A vaccine for human use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.